Spark Therapeutics Inc. | Ownership
Companies that own Spark Therapeutics Inc.
Fidelity Management & Research Co.
5,495,364
14.77%
165,428
0.03%
06/30/2018
Wellington Management Co. LLP
3,540,829
9.51%
-239,591
0.04%
06/30/2018
T. Rowe Price Associates, Inc.
3,033,132
8.15%
-876,736
0.03%
06/30/2018
The Vanguard Group, Inc.
2,687,102
7.22%
102,212
0.01%
06/30/2018
BlackRock Fund Advisors
2,361,366
6.35%
203,262
0.01%
06/30/2018
JPMorgan Investment Management, Inc.
1,681,718
4.51%
-12,858
0.03%
06/30/2018
Federated Global Investment Management Corp.
1,524,102
4.09%
26,314
0.67%
06/30/2018
SSgA Funds Management, Inc.
1,497,792
4.01%
-278,573
0.01%
06/30/2018
Baker Bros. Advisors LP
1,384,130
3.72%
0
0.55%
06/30/2018
Lord, Abbett & Co. LLC
1,195,494
3.21%
892,645
0.19%
06/30/2018
| Address |
3737 Market Street
Philadelphia Pennsylvania 19104
United States
|
|
Employees
|
- |
| Website |
http://www.sparktx.com |
| Updated |
07/08/2019 |
| Spark Therapeutics, Inc. engages in the research, development, and commercialization of gene therapies. Its product portfolio intends to treat inherited retinal sickness, liver-mediated, and neurodegenerative diseases. The company was founded by Jean Bennett, Beverly Davidson, Katherine A. |
